Account creation (email + password) is required upfront after medication selection but before clinical screening, the full-body photo step is unusual and slows the flow, and the four-step consent stack at the end (off-label, individualized treatment, truthfulness, GLP-1 indication) adds checkbox count
Building a long-term GLP-1 strategy Whether or not you decide to alternate, the bigger picture matters more than any individual medication decision
treated with dipeptidyl peptidase 4 (DPP-4) inhibitors, including sitagliptin, vildagliptin, saxagliptin, linagliptin, gemigliptin, teneligliptin, alogliptin, evogliptin, and anagliptin ( n =64,269)
Access to insurance coverage may reduce these costs for eligible patients